George M. Milne Jr., Director at Amylyx Pharmaceuticals, Inc. (AMLX), bought 26,315 shares at $19.00 ($500K) on 2022-01-06, disclosed to the SEC on 2022-01-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| AUPH | BUY | 2023-03-06 | $178K | — | Filing → |
| AUPH | BUY | 2022-03-08 | $54K | — | Filing → |
| AUPH | BUY | 2021-03-09 | $65K | — | Filing → |